Trump is meeting with pharmaceutical companies who are actively working to develop the COVID-19 vaccine. 

The press office sends these details on the president’s upcoming meeting with coronavirus stakeholders:

Today, President Donald J. Trump will meet with pharmaceutical companies who are actively working to develop the COVID-19 vaccine to discuss how the United States Federal Government can help accelerate vaccine development.

The Trump Administration continues its whole-of-government approach to combatting the spread of coronavirus because the safety of the American people remains the highest priority for President Trump.

The following individuals are expected to attend:

The White House

President Donald J. Trump

Vice President Mike Pence

Mick Mulvaney, Acting White House Chief of Staff

Chris Liddell, Assistant to the President and Deputy Chief of Staff for Policy Coordination 

Kellyanne Conway, Assistant to the President and Senior Counselor

Marc Short, Assistant to the President and Chief of Staff to the Vice President 

Larry Kudlow, Assistant to the President and Director of the National Economic Council

Joseph Grogan, Assistant to the President and Director of the Domestic Policy Council

Tim Pataki, Deputy Assistant to the President and Director of the Office of Public Liaison 

Ambassador Debbie Brix, White House Corona Virus Response Coordinator 

Trump Administration

Secretary Alex Azar, Department of Health and Human Services 

Dr. Robert Redfield, Director, Centers for Disease Control and Prevention

Dr. Anne Schuchat, Principal Deputy Director, Centers for Disease Control and Prevention 

Dr. Stephen Hahn, Commissioner of Food and Drugs, Food and Drug Administration 

Dr. Anthony Fauci, Director, National Institute of Allergy and Infectious Diseases

Executives of Pharmaceutical Companies

Emma Walmsley, CEO, GlaxoSmithKline

Dr. J. Joseph Kim, CEO, Inovio Pharmaceuticals

Stéphane Bancel, CEO, Moderna

Dr. Leonard Schleifer, CEO, Regeneron Pharmaceuticals

Stan C. Erck, CEO, President, and Director, Novorax

Daniel Menichella, CEO, CureVac

David O’Day, Chairman of the Board of Directors and CEO, Gilead

Dr. Paul Stoffels, Vice Chairman of the Executive Committee and Chief Scientific Officer, Johnson and Johnson

Dr. Mikael Dolsten, Chief Scientific Officer and President Worldwide Research, Development and Medical, Pfizer Inc.

John Shiver, Senior Vice President, Global Vaccine Research and Development, Sanofi

The White House Press Pool

Produced by members of the White House Correspondents Association (WHCA), these brief Pool Reports track American president. The White House Press Pool is composed of the members of the White House...